| For: | Bacigalupo ML, Manzi M, Rabinovich GA, Troncoso MF. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. World J Gastroenterol 2013; 19(47): 8831-8849 [PMID: 24379606 DOI: 10.3748/wjg.v19.i47.8831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/8831.htm |
| Number | Citing Articles |
| 1 |
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020; 9(4) doi: 10.3390/cells9040875
|
| 2 |
Mehmet Ulu, Ahmet Alacacioglu, Esma Yuksel, Baris O. Pamukk, Giray Bozkaya, Alpay Ari, Arif Yuksel, Gulten Sop, Inci Alacacioglu. Prognostic Significance of Serum Galectin-3 Levels in Patients with Hepatocellular Cancer and Chronic Viral Hepatitis. Saudi Journal of Gastroenterology 2015; 21(1) doi: 10.4103/1319-3767.151228
|
| 3 |
Jiamin Xu, Haiyan Fu, Yina Yang, Haiyan Yu, Xin Ai, Yunjie Lei, Weimin Bao, Yingmei Tang. Modulation of CXCR1 and CXCR3 expression on NK cells via Tim-3 in a murine model of primary biliary cholangitis. Molecular Immunology 2021; 135 doi: 10.1016/j.molimm.2021.04.014
|
| 4 |
Chandan Kishor, Renee L. Ross, Helen Blanchard. Lactulose as a novel template for anticancer drug development targeting galectins. Chemical Biology & Drug Design 2018; 92(4) doi: 10.1111/cbdd.13348
|
| 5 |
Ghulam Md Ashraf, Asma Perveen, Shams Tabrez, Nasimudeen R. Jabir, Ghazi A. Damanhouri, Syed Kashif Zaidi, Naheed Banu. GeNeDis 2014. Advances in Experimental Medicine and Biology 2015; 822 doi: 10.1007/978-3-319-08927-0_10
|
| 6 |
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami. The CCL20-CCR6 Axis in Cancer Progression. International Journal of Molecular Sciences 2020; 21(15) doi: 10.3390/ijms21155186
|
| 7 |
Hugo R. Rosen, Lucy Golden-Mason, Ann K. Daly, Ivana Yang, Christopher P. Day. Variants in the LGALS9 Gene Are Associated With Development of Liver Disease in Heavy Consumers of Alcohol. Clinical Gastroenterology and Hepatology 2016; 14(5) doi: 10.1016/j.cgh.2015.11.005
|
| 8 |
Xuejing Pei, Jiahui Zhu, Yuchen Wang, Fali Zhang, Yufeng He, Yuchun Li, Yunlong Si. Placental galectins: a subfamily of galectins lose the ability to bind β-galactosides with new structural features. Biology of Reproduction 2023; 109(6) doi: 10.1093/biolre/ioad114
|
| 9 |
Helen Blanchard, Khuchtumur Bum-Erdene, Mohammad Hussaini Bohari, Xing Yu. Galectin-1 inhibitors and their potential therapeutic applications: a patent review. Expert Opinion on Therapeutic Patents 2016; 26(5) doi: 10.1517/13543776.2016.1163338
|
| 10 |
Albert J. Czaja. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management. Digestive Diseases and Sciences 2018; 63(7) doi: 10.1007/s10620-018-5072-x
|
| 11 |
Sharad Chawla, Timothy A. Warren, Leesa F. Wockner, Duncan L. J. Lambie, Ian S. Brown, Thomas P. C. Martin, Rajiv Khanna, Graham R. Leggatt, Benedict J. Panizza. Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread. Cancer Immunology, Immunotherapy 2016; 65(2) doi: 10.1007/s00262-015-1788-z
|
| 12 |
Lucy Golden‐Mason, Hugo R. Rosen. Galectin‐9: Diverse roles in hepatic immune homeostasis and inflammation. Hepatology 2017; 66(1) doi: 10.1002/hep.29106
|
| 13 |
Mengyu Hu, Rui Zhang, Jiaren Yang, Chenshu Zhao, Wei Liu, Yuan Huang, Hao Lyu, Shuai Xiao, Dong Guo, Cefan Zhou, Jingfeng Tang. The role of N-glycosylation modification in the pathogenesis of liver cancer. Cell Death & Disease 2023; 14(3) doi: 10.1038/s41419-023-05733-z
|
| 14 |
Kieko Hara, Tsuyoshi Saito, Takuo Hayashi, Keiko Mitani, Kazuya Takamochi, Shiaki Oh, Kenji Suzuki, Takashi Yao. Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma. Virchows Archiv 2017; 471(3) doi: 10.1007/s00428-017-2202-3
|
| 15 |
Claire Lhuillier, Clément Barjon, Valentin Baloche, Toshiro Niki, Aurore Gelin, Rami Mustapha, Laetitia Claër, Sylviane Hoos, Yoichi Chiba, Masaki Ueno, Mitsuomi Hirashima, Ming Wei, Olivier Morales, Bertrand Raynal, Nadira Delhem, Olivier Dellis, Pierre Busson, Ivan R. Nabi. Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9. PLOS ONE 2018; 13(9) doi: 10.1371/journal.pone.0202512
|
| 16 |
V. A. Kovalevа, N. S. Zhevnerova, T. V. Antonova. Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C. Terapevticheskii arkhiv 2021; 93(2) doi: 10.26442/00403660.2021.02.200623
|
| 17 |
María L. Bacigalupo, Malena Manzi, María V. Espelt, Lucas D. Gentilini, Daniel Compagno, Diego J. Laderach, Carlota Wolfenstein‐Todel, Gabriel A. Rabinovich, María F. Troncoso. Galectin‐1 Triggers Epithelial‐Mesenchymal Transition in Human Hepatocellular Carcinoma Cells. Journal of Cellular Physiology 2015; 230(6) doi: 10.1002/jcp.24865
|
| 18 |
YOSHIHIRO KAMADA, MOTOYA SATO, SACHIHO KIDA, MAAYA AKITA, KAYO MIZUTANI, HIRONOBU FUJII, TOMOAKI SOBAJIMA, YUICHI YOSHIDA, SHINICHIRO SHINZAKI, SHINJI TAKAMATSU, TETSUO TAKEHARA, EIJI MIYOSHI. N-Acetylglucosaminyltransferase V exacerbates concanavalin A-induced hepatitis in mice. Molecular Medicine Reports 2015; 11(5) doi: 10.3892/mmr.2015.3168
|
| 19 |
Minpu Zhang, Cun Liu, Ye Li, Huayao Li, Wenfeng Zhang, Jingyang Liu, Liquan Wang, Changgang Sun. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target. Frontiers in Cell and Developmental Biology 2024; 11 doi: 10.3389/fcell.2023.1332205
|
| 20 |
Tanja Freichel, Dominic Laaf, Miriam Hoffmann, Patrick B. Konietzny, Viktoria Heine, Robert Wawrzinek, Christoph Rademacher, Nicole L. Snyder, Lothar Elling, Laura Hartmann. Effects of linker and liposome anchoring on lactose-functionalized glycomacromolecules as multivalent ligands for binding galectin-3. RSC Advances 2019; 9(41) doi: 10.1039/C9RA05497A
|
| 21 |
. 2024; doi: 10.70675/7c132518z8997z4d01z8084z87c06a661e5a
|
| 22 |
Pablo Carabias, María V. Espelt, María L. Bacigalupo, Paola Rojas, Luciana Sarrias, Ayelén Rubin, Nicolás A. Saffioti, María T. Elola, Juan P. Rossi, Carlota Wolfenstein-Todel, Gabriel A. Rabinovich, María F. Troncoso. Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression. Cell Death & Disease 2022; 13(1) doi: 10.1038/s41419-022-04520-6
|
| 23 |
Malena Manzi, María L. Bacigalupo, Pablo Carabias, María T. Elola, Carlota Wolfenstein-Todel, Gabriel A. Rabinovich, María V. Espelt, María F. Troncoso. Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells. Journal of Cellular Physiology 2016; 231(7) doi: 10.1002/jcp.25244
|
| 24 |
Claire Lhuillier, Clément Barjon, Toshiro Niki, Aurore Gelin, Françoise Praz, Olivier Morales, Sylvie Souquere, Mitsuomi Hirashima, Ming Wei, Olivier Dellis, Pierre Busson. Impact of Exogenous Galectin-9 on Human T Cells. Journal of Biological Chemistry 2015; 290(27) doi: 10.1074/jbc.M115.661272
|
| 25 |
Siyu Xiao, Jinfeng Liu, Shiguang Huang, Fangli Lu. Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model. Parasitology Research 2016; 115(2) doi: 10.1007/s00436-015-4784-5
|
| 26 |
Alison C. Mackinnon, Dimitar Tonev, Brian Jacoby, Massimo Pinzani, Robert J. Slack. Galectin-3: therapeutic targeting in liver disease. Expert Opinion on Therapeutic Targets 2023; 27(9) doi: 10.1080/14728222.2023.2258280
|
| 27 |
Mohammadjavad Sotoudeheian. Galectin-3 and Severity of Liver Fibrosis in Metabolic
Dysfunction-Associated Fatty Liver Disease. Protein & Peptide Letters 2024; 31(4) doi: 10.2174/0109298665301698240404061300
|
| 28 |
. 2020; doi: 10.70675/dbf8523bze81fz4cd8z9f6az8d4db79d8ff0
|
| 29 |
Tahereh Setayesh, Steven D. Colquhoun, Yu-Jui Yvonne Wan. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma. Liver Research 2020; 4(4) doi: 10.1016/j.livres.2020.11.001
|
| 30 |
Aki Juhani Käräjämäki, Olli Kettunen, Samuli Lepojärvi, Olli-Pekka Koivurova, Y. Antero Kesäniemi, Heikki Huikuri, Olavi Ukkola, Gianfranco D. Alpini. Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population. PLOS ONE 2017; 12(3) doi: 10.1371/journal.pone.0173855
|
| 31 |
Magda Assem, Rady E. El-Araby, Ahmed A. Al-Karmalawy, Reem Nabil, Mohamed A. M. Kamal, Amany Belal, Heba I. Ghamry, Mohammed A. S. Abourehab, Mohammed M. Ghoneim, Mohammad Y. Alshahrani, Asmaa A. El Leithy. Promoter methylation might shift the balance of Galectin-3 & 12 expression in de novo adult acute myeloid leukemia patients. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1122864
|
| 32 |
Vassilios Aslanis, Michael Gray, Robert J. Slack, Fredrik R. Zetterberg, Dimitar Tonev, De Phung, Becky Smith, Brian Jacoby, Hans Schambye, Zahari Krastev, Anna-Lena Ungell, Bertil Lindmark. Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment. Clinical Drug Investigation 2024; 44(10) doi: 10.1007/s40261-024-01395-7
|
| 33 |
Ganimete Bajraktari, Tanja Elger, Muriel Huss, Johanna Loibl, Andreas Albert, Arne Kandulski, Martina Müller, Hauke Christian Tews, Christa Buechler. Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis. International Journal of Molecular Sciences 2024; 25(9) doi: 10.3390/ijms25094765
|
| 34 |
Farheen Alam. Incidental Findings of Benign Mesenchymal Tumours during Laparoscopic Gastric Mini Bypass Surgery: Two Case Reports. International Clinical Pathology Journal 2015; 1(4) doi: 10.15406/icpjl.2015.01.00019
|
| 35 |
Sanaa S. Ahmed, Amel S. Alsedfy, Wael M. Taha, Nesrin S. Tolba. Differential immunohistochemical expression of Galectin-1 and Galectin-3 in renal cell carcinoma. Egyptian Journal of Pathology 2024; 44(1) doi: 10.4103/egjp.egjp_6_24
|
| 36 |
Jian He, Yongheng Hou, Fangli Lu. Blockage of Galectin-Receptor Interactions Attenuates Mouse Hepatic Pathology Induced by Toxoplasma gondii Infection. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.896744
|
| 37 |
Koji Fujita, Toshiro Niki, Takako Nomura, Kyoko Oura, Tomoko Tadokoro, Teppei Sakamoto, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Noriyuki Kuroda, Takeshi Arai, Naoki Nishimoto, Takashi Himoto, Mitsuomi Hirashima, Tsutomu Masaki. Correlation between serum galectin‐9 levels and liver fibrosis. Journal of Gastroenterology and Hepatology 2018; 33(2) doi: 10.1111/jgh.13851
|
| 38 |
Fei Kong, Meishan Jin, Donghui Cao, Zhifang Jia, Yawen Liu, Jing Jiang. Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma. PeerJ 2020; 8 doi: 10.7717/peerj.9949
|
| 39 |
Doug Terry, Brian S. Robinson. The Sugar-Coated Truth of Alcohol-Associated Liver Disease. The American Journal of Pathology 2026; 196(1) doi: 10.1016/j.ajpath.2025.07.013
|
| 40 |
Yue Li, Shou-Li Yuan, Jing-Ya Yin, Kun Yang, Xin-Gang Zhou, Wen Xie, Qi Wang. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis. World Journal of Gastrointestinal Oncology 2022; 14(7): 1265-1280 doi: 10.4251/wjgo.v14.i7.1265
|
| 41 |
Ruiqi He, Huahong Duan, Ke Zhang, Hao Li, Xing Yu. A functional switch of Galectin-1: A glycan-dependent driver of liver cancer progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2026; 1881(2) doi: 10.1016/j.bbcan.2026.189543
|
| 42 |
Marlen Spirk, Sebastian Zimny, Maximilian Neumann, Nichole McMullen, Christopher J. Sinal, Christa Buechler. Chemerin-156 is the Active Isoform in Human Hepatic Stellate Cells. International Journal of Molecular Sciences 2020; 21(20) doi: 10.3390/ijms21207555
|
| 43 |
Diego D. Santos, Gisela R.S. Sasso, Nycole M. Belote, Rafael André da Silva, Izabella Lice, Rebeca D. Correia-Silva, Fernanda T. Borges, Adriana A.F. Carbonel, Cristiane D. Gil. Galectin-3 is a key hepatoprotective molecule against the deleterious effect of cisplatin. Life Sciences 2023; 318 doi: 10.1016/j.lfs.2023.121505
|
| 44 |
Poonamjot Deol, Jane R. Evans, Joseph Dhahbi, Karthikeyani Chellappa, Diana S. Han, Stephen Spindler, Frances M. Sladek, Jonathan Peterson. Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver. PLOS ONE 2015; 10(7) doi: 10.1371/journal.pone.0132672
|
| 45 |
Nicolas Poté, Jérôme Cros, Samira Laouirem, Jérôme Raffenne, Magda Negrão, Miguel Albuquerque, Pierre Bedossa, Miguel Godinho Ferreira, Slimane Ait Si Ali, Rita Fior, Valérie Paradis. The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma. Liver International 2020; 40(4) doi: 10.1111/liv.14381
|
| 46 |
Asahiro Morishita, Kyoko Oura, Tomoko Tadokoro, Tingting Shi, Koji Fujita, Joji Tani, Masanori Atsukawa, Tsutomu Masaki. Galectin-9 in Gastroenterological Cancer. International Journal of Molecular Sciences 2023; 24(7) doi: 10.3390/ijms24076174
|
| 47 |
Shadi Chamseddine, Betul Gok Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu, Michael LaPelusa, Lianchun Xiao, Ryan Sun, Jeffrey S. Morris, Rikita I. Hatia, Manal Hassan, Dan G. Duda, Maria Diab, Amr Mohamed, Ahmed Nassar, Hesham M. Amin, Ahmed Omar Kaseb. Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. Journal of Immunotherapy and Precision Oncology 2024; 7(4) doi: 10.36401/JIPO-24-6
|
| 48 |
Thomas Grewal, Hauke Christian Tews, Christa Buechler. Galectin-3—Insights from Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. International Journal of Molecular Sciences 2025; 26(13) doi: 10.3390/ijms26136101
|
| 49 |
Lin Liang, Ya-Mei Zhang, Ya-Wen Shen, Ai-Ping Song, Wen-Li Li, Li-Fang Ye, Xin Lu, Guo-Chun Wang, Qing-Lin Peng. Aberrantly Expressed Galectin-9 Is Involved in the Immunopathogenesis of Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.628128
|
| 50 |
Yang An, Shixue Xu, Yiting Liu, Xiangbo Xu, Cyriac Abby Philips, Jiang Chen, Nahum Méndez-Sánchez, Xiaozhong Guo, Xingshun Qi. Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.744518
|
| 51 |
Nevena M Gajovic, Ivan P Jovanovic, Miodrag V Jocic, Bojan Stojanovic, Irfan F Corovic, Nevena Todorovic, Bojana J Simovic Markovic, Amedeo Amedei. Exploring the impact of galectins on liver cancer: From immunopathogenesis to potential targets. World Journal of Gastroenterology 2025; 31(25): 107260 doi: 10.3748/wjg.v31.i25.107260
|
| 52 |
Tongtong Xu, Fujun Cao, Ruihan Zhou, Qin Chen, Jian Zhong, Yulin Wang, Chaoxin Xiao, Banglei Yin, Chong Chen, Chengjian Zhao. A novel 3D visualization method in mice identifies the periportal lamellar complex (PLC) as a key regulator of hepatic ductal and neuronal branching morphogenesis. eLife 2026; 14 doi: 10.7554/eLife.108669.5
|
| 53 |
Koji Fujita, Hisakazu Iwama, Kyoko Oura, Tomoko Tadokoro, Eri Samukawa, Teppei Sakamoto, Takako Nomura, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Takashi Himoto, Mitsuomi Hirashima, Tsutomu Masaki. Cancer Therapy Due to Apoptosis: Galectin-9. International Journal of Molecular Sciences 2017; 18(1) doi: 10.3390/ijms18010074
|
| 54 |
Qi-Hang Yan, Chen-Di Xu, Zhen-Guo Li, Yu-Zhen Zheng, Wing-Shing Wong, Da-Chuan Liang, Jie Yang, Wu-Guang Chang, Jun-Ye Wang. LGALS1 drives chemoresistance in esophageal squamous cell carcinoma by modulating epithelial-mesenchymal transition and tumor immunity. World Journal of Gastroenterology 2026; 32(18): 114713 doi: 10.3748/wjg.v32.i18.114713
Abstract(146) |
Core Tip(127) |
Full Article(HTML)(575)
|
Full Article (PDF)-35556K(582)
|
Full Article with Cover (PDF)-35875K(196)
|
Full Article (XML)-171K(34)
|
Audio-2187K(14)
|
Peer-Review Report-239K(61)
|
Answering Reviewers-56K(36)
|
Supplementary Material-566K(35)
|
Times Cited (0)
|
Total Visits (1494)
|
Open
|
| 55 |
Weiqin Zhang, Ting Shao, Caiyan Wang, Shaogui Wang, Lin An. Advances in pharmacological interventions for hepatic fibrosis: from pathogenic mechanisms to novel therapeutic targets. Annals of Medicine 2026; 58(1) doi: 10.1080/07853890.2026.2613502
|
| 56 |
Hua Tian, Yan Zhou, Gaoxiang Yang, Yang Geng, Sai Wu, Yabin Hu, Kai Lin, Wei Wu. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells. Oncology Reports 2016; 36(3) doi: 10.3892/or.2016.4942
|
| 57 |
Yu-An Hsu, Ching-Yao Chang, Joung-Liang Lan, Ju-Pi Li, Hui-Ju Lin, Chih-Sheng Chen, Lei Wan, Fu-Tong Liu. Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells. Journal of Biomedical Science 2020; 27(1) doi: 10.1186/s12929-020-0616-8
|
| 58 |
Tamara Potikha, Ezra Ella, Juan P. Cerliani, Lina Mizrahi, Orit Pappo, Gabriel A. Rabinovich, Eithan Galun, Daniel S. Goldenberg. Galectin-1 is essential for efficient liver regeneration following hepatectomy. Oncotarget 2016; 7(22) doi: 10.18632/oncotarget.9194
|
| 59 |
Veronica L. Massey, Christine E. Dolin, Lauren G. Poole, Shanice V. Hudson, Deanna L. Siow, Guy N. Brock, Michael L. Merchant, Daniel W. Wilkey, Gavin E. Arteel. The hepatic “matrisome” responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice. Hepatology 2017; 65(3) doi: 10.1002/hep.28918
|
| 60 |
María L Bacigalupo, Pablo Carabias, María F Troncoso. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression. World Journal of Gastroenterology 2017; 23(29): 5266-5281 doi: 10.3748/wjg.v23.i29.5266
|
| 61 |
Eric Felli, Yelidousi Nulan, Sonia Selicean, Cong Wang, Jordi Gracia-Sancho, Jaume Bosch. Emerging Therapeutic Targets for Portal Hypertension. Current Hepatology Reports 2023; 22(1) doi: 10.1007/s11901-023-00598-4
|
| 62 |
. 2016; doi: 10.70675/d067b27ez2081z49d2z94f5z87680adf071c
|
| 63 |
Liang Chen, Chun Hu, Molly Hood, Juntao Kan, Xiaona Gan, Xue Zhang, Yi Zhang, Jun Du. An Integrated Approach Exploring the Synergistic Mechanism of Herbal Pairs in a Botanical Dietary Supplement: A Case Study of a Liver Protection Health Food. International Journal of Genomics 2020; 2020 doi: 10.1155/2020/9054192
|
| 64 |
Yuanwei Shi, Danting Tang, Xiaoqi Li, Xiaoli Xie, Yufu Ye, Lijuan Wang. Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.889034
|
| 65 |
Sebastian John, Rashmi Mishra. Galectin-9: From cell biology to complex disease dynamics. Journal of Biosciences 2016; 41(3) doi: 10.1007/s12038-016-9616-y
|
| 66 |
Roxana Kiyomi Mizutamari, Juan M. Pérez Sáez, Alejandro J. Cagnoni, Pablo F. Hockl, Mercedes Goin, Santiago Nahuel Villarreal, Gabriel A. Rabinovich. Cell Death - Part D. Methods in Cell Biology 2026; 209 doi: 10.1016/bs.mcb.2026.04.005
|
| 67 |
. 2021; doi: 10.70675/f74abe25z2801z481cza9b8zb9232964c1fa
|
| 68 |
Zhixiong Cai, Yongyi Zeng, Bo Xu, Yunzhen Gao, Sen Wang, Jinhua Zeng, Lihong Chen, Aimin Huang, Xiaolong Liu, Jingfeng Liu. Galectin‐4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma. Cancer Science 2014; 105(11) doi: 10.1111/cas.12536
|
| 69 |
Tatsuo Shimura, Yasuhide Kofunato, Ryo Okada, Rei Yashima, Yoshihisa Koyama, Koji Okada, Kenichiro Araki, Yasuo Hosouchi, Hiroyuki Kuwano, Seiichi Takenoshita. Intranuclear accumulation of galectin-3 is associated with a poor prognosis in patients with invasive intraductal papillary mucinous neoplasm. Annals of Cancer Research and Therapy 2016; 24(1) doi: 10.4993/acrt.24.23
|
| 70 |
Qi Shao, Jing He, Zhiming Chen, Changping Wu. Prognostic role of galectins expression in patients with hepatic cancer. Medicine 2020; 99(15) doi: 10.1097/MD.0000000000019622
|